China Shineway Pharmaceutical Group Limited
CSWYF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $755 | $699 | $718 | $710 |
| - Cash | $6,140 | $5,889 | $725 | $660 |
| + Debt | $347 | $301 | $1 | $2 |
| Enterprise Value | -$5,038 | -$4,888 | -$7 | $52 |
| Revenue | $3,778 | $4,517 | $588 | $498 |
| % Growth | -16.4% | 668% | 18% | – |
| Gross Profit | $2,832 | $3,394 | $437 | $373 |
| % Margin | 75% | 75.1% | 74.4% | 74.8% |
| EBITDA | $1,221 | $1,252 | $145 | $121 |
| % Margin | 32.3% | 27.7% | 24.7% | 24.4% |
| Net Income | $840 | $137 | $108 | $86 |
| % Margin | 22.2% | 3% | 18.3% | 17.3% |
| EPS Diluted | 1.11 | 0.18 | 0.14 | 0.11 |
| % Growth | 516.7% | 28.6% | 27.3% | – |
| Operating Cash Flow | $963 | $141 | $179 | $120 |
| Capital Expenditures | -$140 | -$20 | -$19 | -$14 |
| Free Cash Flow | $823 | $120 | $159 | $106 |